These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28043654)

  • 41. KIF5C: a new binding partner for protein kinase CK2 with a preference for the CK2alpha' subunit.
    Schäfer B; Götz C; Dudek J; Hessenauer A; Matti U; Montenarh M
    Cell Mol Life Sci; 2009 Jan; 66(2):339-49. PubMed ID: 19011756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The kinesin I family member KIF5C is a novel substrate for protein kinase CK2.
    Schäfer B; Götz C; Montenarh M
    Biochem Biophys Res Commun; 2008 Oct; 375(2):179-83. PubMed ID: 18682247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2.
    Lindenblatt D; Nickelsen A; Applegate VM; Jose J; Niefind K
    J Med Chem; 2020 Jul; 63(14):7766-7772. PubMed ID: 32589844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein Kinase CK2α', More than a Backup of CK2α.
    Montenarh M; Götz C
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta.
    Bibby AC; Litchfield DW
    Int J Biol Sci; 2005; 1(2):67-79. PubMed ID: 15951851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
    Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K
    Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.
    Gibson SA; Yang W; Yan Z; Qin H; Benveniste EN
    J Immunol; 2018 Jul; 201(2):383-392. PubMed ID: 29891553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
    Li X; Guan B; Maghami S; Bieberich CJ
    Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process.
    Dörr J; Kartarius S; Götz C; Montenarh M
    Mol Cell Biochem; 2008 Sep; 316(1-2):187-93. PubMed ID: 18553058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2α' levels.
    Olsen BB; Fischer U; Rasmussen TL; Montenarh M; Meese E; Fritz G; Issinger OG
    Mol Cell Biochem; 2011 Oct; 356(1-2):139-47. PubMed ID: 21750982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary and secondary interactions between CK2alpha and CK2beta lead to ring-like structures in the crystals of the CK2 holoenzyme.
    Niefind K; Issinger OG
    Mol Cell Biochem; 2005 Jun; 274(1-2):3-14. PubMed ID: 16335523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of a novel testis-specific gene CKT2, which encodes a substrate for protein kinase CK2.
    Bai X; Silvius D; Chan ED; Escalier D; Xu SX
    Nucleic Acids Res; 2009 May; 37(8):2699-711. PubMed ID: 19273531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.
    Niefind K; Issinger OG
    Biochim Biophys Acta; 2010 Mar; 1804(3):484-92. PubMed ID: 19796713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catalytic activity of mutants of yeast protein kinase CK2alpha.
    Sajnaga E; Kubiński K; Szyszka R
    Acta Biochim Pol; 2008; 55(4):767-76. PubMed ID: 19015772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand.
    Raaf J; Guerra B; Neundorf I; Bopp B; Issinger OG; Jose J; Pietsch M; Niefind K
    ACS Chem Biol; 2013 May; 8(5):901-7. PubMed ID: 23474121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
    Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H
    Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.
    Tang S; Zhang N; Zhou Y; Cortopassi WA; Jacobson MP; Zhao LJ; Zhong RG
    Mol Inform; 2019 Mar; 38(3):e1800089. PubMed ID: 30307134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods.
    Jiang HM; Dong JK; Song K; Wang TD; Huang WK; Zhang JM; Yang XY; Shen Y; Zhang J
    Acta Pharmacol Sin; 2017 Dec; 38(12):1691-1698. PubMed ID: 28748912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a high-throughput screening-compatible assay to identify inhibitors of the CK2α/CK2β interaction.
    Hochscherf J; Lindenblatt D; Steinkrüger M; Yoo E; Ulucan Ö; Herzig S; Issinger OG; Helms V; Götz C; Neundorf I; Niefind K; Pietsch M
    Anal Biochem; 2015 Jan; 468():4-14. PubMed ID: 25233003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural basis for the design of bisubstrate inhibitors of protein kinase CK2 provided by complex structures with the substrate-competitive inhibitor heparin.
    Schnitzler A; Niefind K
    Eur J Med Chem; 2021 Mar; 214():113223. PubMed ID: 33571828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.